Loading…
Certara, Inc. is projected to rise to $9.05 by 2027, a +12% move from its current price of $8.10. CERT is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/1/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 2 | $7.85 | $8.10 | $8.36 | +0.01% |
| Aug 3 | $7.74 | $8.10 | $8.48 | +0.01% |
| Aug 4 | $7.66 | $8.10 | $8.56 | +0.02% |
| Aug 5 | $7.60 | $8.10 | $8.64 | +0.02% |
| Aug 6 | $7.54 | $8.10 | $8.70 | +0.03% |
| Aug 7 | $7.49 | $8.10 | $8.76 | +0.04% |
| Aug 8 | $7.45 | $8.10 | $8.82 | +0.04% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $7.45 | $8.10 | $8.82 | +0.04% |
| Week 2 | $7.19 | $8.11 | $9.14 | +0.08% |
| Week 3 | $7.00 | $8.11 | $9.39 | +0.12% |
| Week 4 | $6.85 | $8.11 | $9.61 | +0.17% |
| Week 5 | $6.72 | $8.12 | $9.81 | +0.21% |
| Week 6 | $6.60 | $8.12 | $9.99 | +0.25% |
| Week 7 | $6.49 | $8.12 | $10.16 | +0.29% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Certara, Inc. is a healthcare company that provides technology-driven services and software products for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access across the Americas, Europe, the Middle East, Africa, and Asia Pacific.
Its portfolio includes model-informed drug development solutions; biosimulation solutions to predict pharmacokinetics and pharmacodynamics; Simcyp simulator, a mechanistic biosimulation platform for physiologically based pharmacokinetic simulation; Simcyp Discovery for scientists working on pre-investigational new drug and translational stages; Simcyp Biopharmaceutics for formulation scientists; and Simcyp Secondary Intelligence that integrates toxicology with quantitative analysis of large networks of molecular and functional biological changes. It also provides Phoenix WinNonlin, a platform for non-compartmental analysis; Phoenix cloud that offers a secured and validated Certara Amazon Web Services workspace; Phoenix NLME, a population modeling and simulation software; and Pirana Modeling Workbench, which provides modelers with a structure to facilitate the iterative processes.
In addition, it offers Chemaxon JChem engines, a chemical search engine; Chemaxon Compound Registration that supports a streamlined lead optimization process workflow; Chemaxon Design Hub, a design and tracking platform; Certara D360 software, a scientific informatics system; and Chemaxon Marvin, a chemical drawing tool. Further, the company provides pinnacle 21, a cloud-based platform for clinical data automation, standardization, and validation; Pinnacle 21 Data Exchange to define data standards and specifications; Metadata Repository that enables study design using controlled and standardized data; CoAuthor software, which creates and writes regulatory submissions and medical publications; and GlobalSubmit, a submissions management software. Certara Inc.
was founded in 2008 and is headquartered in Radnor, Pennsylvania.
Certara, Inc. (CERT) operates in the Healthcare sector and currently trades at $8.09 per share with a market capitalization of $1.26B. It ranks 2,365 by market cap among listed companies.
The price outlook is supported by a multi-year forecast that shows upside beyond the near term. In 2026 the average price is $8.09 with a max of $10.47 and a min of $4.48, reflecting a Neutral sentiment for that year. Looking further out, 2030 shows an average price of $16.51 with a max of $24.79 and a min of $11.89, yielding a 104.1% ROI and a bullish outlook.
By 2040 the average price is projected at $35.70 (max $63.44, min $21.42) with a 341.3% ROI and bullish sentiment. The 2050 forecast envisions an average of $81.83 (max $160.62, min $42.45), a 911.5% ROI, and bullish sentiment across that horizon.
A major floor 45.4% below — a decisive break under it would weaken the trend.
The nearest floor, 34.1% below — buyers have tended to step in here.
Price is pressing into resistance (0.0% away) — a breakout level to watch.
A major ceiling 22.7% above — clearing it would confirm fresh momentum.
Key CERT support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of CERT market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $7.93 | Buy | $7.86 | Buy |
| MA 10 | $7.49 | Buy | $7.61 | Buy |
| MA 20 | $7.20 | Buy | $7.22 | Buy |
| MA 50 | $6.25 | Buy | $6.63 | Buy |
| MA 100 | $6.08 | Buy | $6.65 | Buy |
| MA 200 | $7.58 | Buy | $7.52 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 69.41 | Neutral |
| Stoch RSI (14) | 73.28 | Neutral |
| CCI (20) | 149.54 | Buy |
| Williams %R (14) | 0.00 | Info |
| MACD (12,26,9) | 0.07 | Buy |
| ROC (12) | 14.73 | Buy |
| Bollinger %B (20,2) | 0.97 | Neutral |
| Stochastic %K (14) | 100.00 | Sell |
| TRIX (15) | 0.95 | Buy |
| Awesome (5,34) | 1.27 | Buy |
| Ultimate (7,14,28) | 78.43 | Sell |
| Momentum (10) | 1.17 | Buy |
| Aroon Osc (25) | 100.00 | Buy |
| Hull MA (9) | 8.19 | Sell |
| ADX (14) | 28.36 | Buy |
| ATR (14) | 0.21 | Info |
The 30-day technical picture is bullish, with RSI(14) at 70.0 and a momentum tilt supporting upside potential. The 50-day simple moving average sits at $6.12 and the 200-day simple moving average at $7.62, keeping the near-term trajectory weighted toward gains.
Near-term support is identified at $5.34 and resistance at $8.09. The 30-day price range runs from $6.56 to $9.98, indicating that a test of the resistance area near $8.09 or beyond is plausible in the near term. Annualized volatility stands at 60%, underscoring substantial price variability over the year.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $4.48 | $8.10 | $10.52 | 0% | Neutral | |
| $7.10 | $9.05 | $12.25 | +12% | Neutral | |
| $8.29 | $10.92 | $15.44 | +35% | Bullish | |
| $10.28 | $13.93 | $20.36 | +72% | Bullish | |
| $11.96 | $16.61 | $24.97 | +105% | Bullish | |
| $12.23 | $17.38 | $26.75 | +115% | Bullish | |
| $12.87 | $18.68 | $29.40 | +131% | Bullish | |
| $13.46 | $19.92 | $31.97 | +146% | Bullish | |
| $13.79 | $20.81 | $33.99 | +157% | Bullish | |
| $16.62 | $25.54 | $42.41 | +215% | Bullish | |
| $21.57 | $36.01 | $64.09 | +345% | Bullish | |
| $43.01 | $83.15 | $163.52 | +927% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $4.48 | $8.10 | $10.03 | +0.00% |
| September 2026 | $6.84 | $8.13 | $9.98 | +0.42% |
| October 2026 | $6.79 | $8.14 | $10.11 | +0.12% |
| November 2026 | $6.97 | $8.41 | $10.55 | +3.26% |
| December 2026 | $6.85 | $8.31 | $10.52 | -1.20% |
Click any year to see its month-by-month CERT forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect CERT to range from $4.48 to $10.52 through 2026. The $8.10 average target implies a 0% move from current prices. A consolidation phase looks the most probable path here.
The CERT price prediction for 2027 points to an average of $9.05 (low $7.10, high $12.25) — a potential gain of +12% on today's $8.10. Price action looks broadly range-bound.
In 2028, CERT is projected to trade between $8.29 and $15.44, averaging $10.92 — a potential gain of +35% from today's $8.10. That is up +21% on the projected 2027 average. Buyers look set to stay in control over this stretch.
Certara, Inc.'s 2029 outlook centres on $13.93, within a $10.28 to $20.36 range. That is up +28% on the projected 2028 average. That marks a +72% change versus current levels. Momentum favours further upside here.
By 2030, CERT could reach as high as $24.97, with a base case around $16.61 and support toward $11.96 — roughly +105% from $8.10. Buyers look set to stay in control over this stretch.
Expect CERT to range from $12.23 to $26.75 through 2031. The $17.38 average target implies a +115% move from current prices. That is up +5% on the projected 2030 average. Momentum favours further upside here.
The CERT price prediction for 2032 points to an average of $18.68 (low $12.87, high $29.40) — a potential gain of +131% on today's $8.10. Buyers look set to stay in control over this stretch.
In 2033, CERT is projected to trade between $13.46 and $31.97, averaging $19.92 — a potential gain of +146% from today's $8.10. That is up +7% on the projected 2032 average. Momentum favours further upside here.
Certara, Inc.'s 2034 outlook centres on $20.81, within a $13.79 to $33.99 range. That is up +4% on the projected 2033 average. That marks a +157% change versus current levels. Buyers look set to stay in control over this stretch.
By 2035, CERT could reach as high as $42.41, with a base case around $25.54 and support toward $16.62 — roughly +215% from $8.10. Momentum favours further upside here.
Expect CERT to range from $21.57 to $64.09 through 2040. The $36.01 average target implies a +345% move from current prices. That is up +41% on the projected 2035 average. Buyers look set to stay in control over this stretch.
The CERT price prediction for 2050 points to an average of $83.15 (low $43.01, high $163.52) — a potential gain of +927% on today's $8.10. Momentum favours further upside here.
Investing $1,000 in CERT today (≈ 123.45679 CERT) could be worth
$10,266
+$9,266 (+927%) by 2050 · US Dollar
Based on the average projected CERT price of $83.15 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in CERTwould be worth at today's price.
$1,000 invested in CERT on Jul 31, 2025 (≈ 101.626015 CERT) would be worth
$823.17
-$176.83 (-17.7%) today · 0.82× · US Dollar
Based on a CERT entry price of $9.84 vs. today's $8.1.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $7.51 | $1,078.56 | +7.9% |
| 1 month ago | $6.73 | $1,203.57 | +20.4% |
| 3 months ago | $6.18 | $1,310.68 | +31.1% |
| 6 months ago | $8.3 | $975.9 | -2.4% |
| 1 year ago | $9.84 | $823.17 | -17.7% |
| All time (5.0y) ago | $26.13 | $309.99 | -69.0% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our CERT forecast.
Our base-case forecast reaches $16.00 around 2030.
Implied market cap at $16.00: $2.49B
The multi-year forecast points to a bullish long-run trajectory, with meaningful upside beyond the near term. In 2030 the average forecast price is $16.51 and the max is $24.79, representing a 104.1% ROI. By 2040 the average is $35.70 with a max of $63.44, yielding a 341.3% ROI.
In 2050 the average climbs to $81.83 and the max to $160.62, for a 911.5% ROI. These figures imply persistent upside across the 2027–2050 horizon, supported by a bullish sentiment for the longer term.
These are estimates, not guarantees, and should be considered in the context of market conditions and other investment risks.
Tap a question to reveal the answer.
Avg $16.51; min $11.89; max $24.79; ROI 104.1%; sentiment BULLISH.
The long-term forecast shows bullish upside with 2030–2050 avg prices rising to $16.51, $35.70, and $81.83 respectively, with ROIs of 104.1%, 341.3%, and 911.5%. Near term (2026) shows an avg of $8.09 and ROI of 0 with Neutral sentiment.
Yes—the max forecast for 2050 is $160.62, so reaching $100 is within the projected high end.
RSI(14) is 70; SMA50 is $6.12; SMA200 is $7.62; support is $5.34; resistance is $8.09; 30-day range is $6.56–$9.98; annualized volatility is 60%.
Min $4.48; Avg $8.09; Max $10.47; ROI 0%; sentiment NEUTRAL.
Certara, Inc. Community Discussion
0Share your Certara, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.